CA2514687A1 — Advenced vitamin c-based composition with enhanced biotransformation and utilization of protein and l-carnitine for nutritional supplementation or the like
Assigned to Individual · Expires 2005-12-09 · 20y expired
What this patent protects
A nutritional supplement and a method of treatment using the same, the supplement comprising Vitamin C generally within a range of 250 milligrams a nd 5000 milligrams, in mixture, with L-Carnitine generally within a range of 10 0 milligrams and 5000 milligrams, and/or one or more…
USPTO Abstract
A nutritional supplement and a method of treatment using the same, the supplement comprising Vitamin C generally within a range of 250 milligrams a nd 5000 milligrams, in mixture, with L-Carnitine generally within a range of 10 0 milligrams and 5000 milligrams, and/or one or more Proteins comprising essential amino acids generally within a range of 1 gram and 150 grams.
Drugs covered by this patent
- Unithroid (LEVOTHYROXINE SODIUM) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.